Sökning: onr:"swepub:oai:DiVA.org:uu-170036" >
Loading and mainten...
-
van Schie, Rianne M F
(författare)
Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data
- Artikel/kapitelEngelska2011
Förlag, utgivningsår, omfång ...
-
2011-06-02
-
Oxford University Press (OUP),2011
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-170036
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-170036URI
-
https://doi.org/10.1093/eurheartj/ehr116DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Mia Wadelius (Uppsala University, Department of Medical Sciences, Clinical pharmacogenomics and osteoporosis) contributed to this study.
-
AIMS: Polymorphisms in CYP2C9 and VKORC1 influence patients' phenprocoumon (PHE) and acenocoumarol (ACE) dose requirements. To provide physicians with tools to estimate the patient's individual dose, we aimed to develop algorithms for PHE and ACE. METHODS AND RESULTS: In two Dutch anticoagulation clinics, data on age, sex, height, weight, co-medication, coumarin derivative doses, and international normalized ratio values were obtained from 624 patients taking PHE and 471 taking ACE. Single nucleotide polymorphisms relevant to coumarin derivative dosing on the CYP2C9 and VKORC1 genes were determined. Using multiple linear regression, we developed genotype-guided and non-genotype-guided algorithms to predict the maintenance dose with patient characteristics and genetic information. In addition, loading doses were derived from the calculated maintenance doses. We performed external validation in an independent data set with 229 PHE and 168 ACE users. CYP2C9 and VKORC1 genotype, weight, height, sex, age, and amiodarone use contributed to the maintenance dose of PHE and ACE. The genotype-guided algorithms explained 55.9% (PHE) and 52.6% (ACE) of the variance of the maintenance dose, the non-genetic algorithms 17.3% (PHE) and 23.7% (ACE). Validation in an independent data set resulted in an explained variation of 59.4% (PHE) and 49.0% (ACE) for the genotype-guided algorithms and for 23.5% (PHE) and 17.8% (ACE) for the non-genotype-guided algorithms, without height and weight as parameters. CONCLUSION: To our knowledge, these are the first genotype-guided loading and maintenance dose algorithms for PHE and ACE using large cohorts. The utility of these algorithms will be tested in randomized controlled trials.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Wessels, Judith A M
(författare)
-
le Cessie, Saskia
(författare)
-
de Boer, Anthonius
(författare)
-
Schalekamp, Tom
(författare)
-
van der Meer, Felix J M
(författare)
-
Verhoef, Talitha I
(författare)
-
van Meegen, Erik
(författare)
-
Rosendaal, Frits R
(författare)
-
Maitland-van der Zee, Anke-Hilse
(författare)
Sammanhörande titlar
-
Ingår i:European Heart Journal: Oxford University Press (OUP)32:15, s. 1909-19170195-668X1522-9645
Internetlänk
Hitta via bibliotek
Till lärosätets databas